Page last updated: 2024-10-31

metoclopramide and Abdominal Obesity

metoclopramide has been researched along with Abdominal Obesity in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
" Long-term use of various drugs and increased risk of diverse side effects is an unavoidable reality in this population of patients."1.51Factors Associated with Insulin Resistance in Women with Migraine: A Cross-Sectional Study. ( Gur-Ozmen, S; Karahan-Ozcan, R, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gur-Ozmen, S1
Karahan-Ozcan, R1

Other Studies

1 other study available for metoclopramide and Abdominal Obesity

ArticleYear
Factors Associated with Insulin Resistance in Women with Migraine: A Cross-Sectional Study.
    Pain medicine (Malden, Mass.), 2019, 10-01, Volume: 20, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Blood Pressure; Body Composition; Bod

2019